Detailed Information on Publication Record
2022
Alteration of primary cilia morphology and associated signalling in ameloblastoma
FILUŠOVÁ, Jana, Iveta PUTNOVA, Pavel HURNÍK, Zdeněk DANĚK, Ctirad MACHÁČEK et. al.Basic information
Original name
Alteration of primary cilia morphology and associated signalling in ameloblastoma
Authors
FILUŠOVÁ, Jana (703 Slovakia), Iveta PUTNOVA (203 Czech Republic, guarantor), Pavel HURNÍK (203 Czech Republic, belonging to the institution), Zdeněk DANĚK (203 Czech Republic, belonging to the institution), Ctirad MACHÁČEK (203 Czech Republic, belonging to the institution), Jan ŠTEMBÍREK (203 Czech Republic), Marcela BUCHTOVÁ (203 Czech Republic, belonging to the institution) and Barbora PUTNOVA MOLDOVAN (203 Czech Republic)
Edition
Archives of Oral Biology, Amsterdam, Elsevier, 2022, 0003-9969
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30208 Dentistry, oral surgery and medicine
Country of publisher
Netherlands
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 3.000
RIV identification code
RIV/00216224:14310/22:00129706
Organization unit
Faculty of Science
UT WoS
000831041300002
Keywords in English
Ameloblastoma; SHH; IFT; Primary cilia
Tags
International impact, Reviewed
Změněno: 13/3/2023 08:02, Mgr. Marie Šípková, DiS.
Abstract
V originále
Objectives: Primary cilium is a cellular organelle with growing significance confirmed in tumour biology. Primary cilia have been associated with fine tuning of numerous cell signalling pathways and the role of this structure in cancer initiation and progression is recently at the forefront of attention. Here, we investigated possible alter-ations in the occurrence of primary cilia and changes of associated signalling in ameloblastoma, which represents the most common odontogenic tumour. Methods: We performed immunohistochemistry to assess the number and morphology of primary cilia in ame-loblastoma tissues. The gene expression of key SHH pathway members was analysed by qPCR. As a functional experiment, we treated a primary ameloblastoma cell line by a SHH pathway inhibitor Sonidegib (LDE225). Results: We uncovered differences in primary cilia distribution and appearance in histological subtypes of ameloblastoma with the highest number of ciliated cells in plexiform and follicular subtypes. SHH protein was located close to primary cilia in ameloblastoma epithelial cells and the expression of molecules downstream of SHH signalling was upregulated. Moreover, the inhibition of SHH pathway by Sonidegib caused downregulation of SHH effector gene GLI1 and cell cycle regulator CCND1 in ameloblastoma primary cell line. The inhibition of SHH signalling also altered the expression of molecules involved in intraflagellar transport. Conclusions: In conclusion, our study uncovered alterations in number of ciliated cells and associated signalling in ameloblastoma, which indicate SHH inhibitors as potential therapeutic target to treat this disease.
Links
NU20-08-00205, research and development project |
|